These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1013 related articles for article (PubMed ID: 30710469)

  • 61. Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and
    Chew KL; La MV; Lin RTP; Teo JWP
    J Clin Microbiol; 2017 Sep; 55(9):2609-2616. PubMed ID: 28592552
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
    Zavascki AP; Nation RL
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993859
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B.
    Pereira GH; Muller PR; Levin AS
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):235-40. PubMed ID: 17350201
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Deciphering polymyxin B minimum inhibitory concentration from colistin minimum inhibitory concentration and vice versa: An analysis on 156 carbapenem-resistant
    Behera B; Jena J; Kar P; Mohanty S; Mahapatra A
    Indian J Med Microbiol; 2018; 36(4):587-589. PubMed ID: 30880712
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.
    Akajagbor DS; Wilson SL; Shere-Wolfe KD; Dakum P; Charurat ME; Gilliam BL
    Clin Infect Dis; 2013 Nov; 57(9):1300-3. PubMed ID: 23840000
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.
    Sobieszczyk ME; Furuya EY; Hay CM; Pancholi P; Della-Latta P; Hammer SM; Kubin CJ
    J Antimicrob Chemother; 2004 Aug; 54(2):566-9. PubMed ID: 15269195
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The safety of polymyxin antibiotics.
    Kelesidis T; Falagas ME
    Expert Opin Drug Saf; 2015; 14(11):1687-701. PubMed ID: 26365594
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Colistin: an update on the antibiotic of the 21st century.
    Biswas S; Brunel JM; Dubus JC; Reynaud-Gaubert M; Rolain JM
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):917-34. PubMed ID: 23030331
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expert Consensus on Polymyxin Antimicrobial Susceptibility Testing and Clinical Interpretation.
    Yang QW; Ma XL; Hu FP; Zhang J; Sun TW; Chen BY; Xu YC; Liu YN; ;
    Chin Med Sci J; 2021 Mar; 36(1):1-16. PubMed ID: 33500098
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies.
    Oliota AF; Penteado ST; Tonin FS; Fernandez-Llimos F; Sanches AC
    Diagn Microbiol Infect Dis; 2019 May; 94(1):41-49. PubMed ID: 30635223
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular mechanisms of polymyxin resistance and detection of mcr genes.
    Mlynarcik P; Kolar M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):28-38. PubMed ID: 30439931
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Manual Reading of Sensititre Broth Microdilution System Panels Improves Accuracy of Susceptibility Reporting for Polymyxin Antibiotics.
    Bellerose MM; Clark AE; Youn JH; Weingarten RA; Crooks CM; Dekker JP; Frank KM
    J Clin Microbiol; 2021 Aug; 59(9):e0033221. PubMed ID: 34165324
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polymyxin B, colistin, and sodium colistimethate.
    Horton J; Pankey GA
    Med Clin North Am; 1982 Jan; 66(1):135-42. PubMed ID: 6278236
    [No Abstract]   [Full Text] [Related]  

  • 74. Causes of polymyxin treatment failure and new derivatives to fill the gap.
    Chiu S; Hancock AM; Schofner BW; Sniezek KJ; Soto-Echevarria N; Leon G; Sivaloganathan DM; Wan X; Brynildsen MP
    J Antibiot (Tokyo); 2022 Nov; 75(11):593-609. PubMed ID: 36123537
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence of Dose Variability and Dosing Below the FDA and EMA Recommendations for Intravenous Colistin (Polymyxin E) Use in Children and Neonates.
    Chin MKY; Hsia Y; Goossens H; Versporten A; Bielicki J; Sharland M; Donà D
    Pediatr Infect Dis J; 2020 Nov; 39(11):1032-1034. PubMed ID: 32773667
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correction to "International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists".
    Pharmacotherapy; 2024 Jan; ():. PubMed ID: 38205910
    [No Abstract]   [Full Text] [Related]  

  • 77. Evaluation of susceptibility testing methods for polymyxin.
    Behera B; Mathur P; Das A; Kapil A; Gupta B; Bhoi S; Farooque K; Sharma V; Misra MC
    Int J Infect Dis; 2010 Jul; 14(7):e596-601. PubMed ID: 20045367
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM
    Pharmacotherapy; 2020 Apr; 40(4):363-367. PubMed ID: 32227354
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Susceptibility testing of the polymyxins: where are we now?
    Humphries RM
    Pharmacotherapy; 2015 Jan; 35(1):22-7. PubMed ID: 25329490
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DRUG USE RECOMMENDATIONS FOR COLISTIN INJECTION IN THE ADULT POPULATION.
    Amir M; Dodani SK; Nasim A; Babar ZU
    J Ayub Med Coll Abbottabad; 2023; 35(4):693-697. PubMed ID: 38406964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.